Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- CheckyesterdayChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page displays a 403 Forbidden message, and the detailed study content is no longer visible, indicating access to the study record is blocked.SummaryDifference18%

- Check22 days agoChange DetectedThe page now lists revision v3.7.0, replacing the previous v3.6.6. This reflects an updated version of the study protocol and statistical analysis plan in the documents section.SummaryDifference0.1%

- Check58 days agoChange DetectedExpanded Access status text was updated to No longer available, replacing the previous Temporarily not available. A new page revision tag Revision: v3.6.5 appears, replacing the old v3.6.4.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter revision tag updated from v3.6.3 to v3.6.4, signaling a site version update. This change does not modify any study content or data.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.1, signaling a new build of the site. It represents a software update rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.